The Top Analysis for Gilead Sciences Inc (GILD)
The top analysis was written by Noah Brody titled Which is the Better Buy? Gilead Sciences vs Bristol-Myers Squibb
Is Gilead Sciences Inc (GILD) a buy?
Based on 3 suggestions, Gilead Sciences Inc(GILD) is recommended as a BUY at $65.19.Are These Ratings Good?
Based on 3 ratings, the average Return is 30.62%.Forecast for Gilead Sciences Inc (GILD)
the two year forecast for GILD is $106.63.
The four year forecast is $119.32